Thomas J. Matthew

13.9k total citations
4 papers, 34 citations indexed

About

Thomas J. Matthew is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Thomas J. Matthew has authored 4 papers receiving a total of 34 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Radiology, Nuclear Medicine and Imaging, 2 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in Thomas J. Matthew's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Thomas J. Matthew is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Thomas J. Matthew collaborates with scholars based in . Thomas J. Matthew's co-authors include Avneesh K. Saini, Genevive Hernandez, Angus M. Sinclair, Maya F. Kotturi, Ling Wang, Bruce A. Keyt, Marvin S. Peterson, Eric W. Humke, Mélanie Desbois and Maya K. Leabman and has published in prestigious journals such as Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Thomas J. Matthew

3 papers receiving 30 citations

Peers

Countries citing papers authored by Thomas J. Matthew

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Matthew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Matthew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Matthew more than expected).

Fields of papers citing papers by Thomas J. Matthew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Matthew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Matthew. The network helps show where Thomas J. Matthew may publish in the future.

Co-authorship network of co-authors of Thomas J. Matthew

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Matthew. A scholar is included among the top collaborators of Thomas J. Matthew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Matthew. Thomas J. Matthew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

#	Work	Indexed citations
1	Abstract 1899: Novel combinations of aplitabart, a DR5 agonist IgM antibody, with ADCs or chemotherapeutic agents lead to robust anti-tumor responses in solid tumor models 2024 ·Cancer Research ·Mélanie Desbois, (unknown), Kevin C. Hart, (unknown), (unknown), Thomas J. Matthew, Maya K. Leabman, Sanela Bilic, Genevive Hernandez, Eric W. Humke, Albert F. Candia, Bruce A. Keyt, Angus M. Sinclair, Maya F. Kotturi, (unknown)	1
2	Abstract 1068: Anti-DR5 agonist IgM antibody IGM-8444 combined with SMAC mimetic birinapant induces strong synergistic tumor cytotoxicity 2022 ·Cancer Research ·(unknown), Mélanie Desbois, (unknown), Thomas J. Matthew, (unknown), Ling Wang, (unknown), (unknown), Miho Oyasu, Maya F. Kotturi, Genevive Hernandez, Xiaohan Liu, Marvin S. Peterson, Eric W. Humke, Bruce A. Keyt, Angus M. Sinclair	2
3	Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199 2021 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Ling Wang, Thomas J. Matthew, (unknown), Avneesh K. Saini, Maya F. Kotturi, Genevive Hernandez, Eric W. Humke, Marvin S. Peterson, Angus M. Sinclair, Bruce A. Keyt	30
4	Abstract 52: Mechanistic evaluation of anti-DR5 IgM antibody IGM-8444 with potent tumor cytotoxicity, without in vitro hepatotoxicity 2021 ·Cancer Research ·(unknown), (unknown), Kevin C. Hart, (unknown), Mélanie Desbois, (unknown), (unknown), (unknown), Yuan Cao, (unknown), Thomas J. Matthew, Ling Wang, Paul R. Hinton, Maya K. Leabman, Genevive Hernandez, Maya F. Kotturi, Eric W. Humke, Angus M. Sinclair, Bruce A. Keyt	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact